Sixfold increased risk of infant HIV infection and high rates of low birth weight among women with HIV/hepatitis B co-infection
Nivolumab improves outcomes in liver cancer study
Daily aspirin therapy linked to lower liver cancer risk
US FDA approves nivolumab immunotherapy for liver cancer
Besifovir and tenofovir exalidex look promising as new hepatitis B drugs
EASL releases updated hepatitis B guidelines at International Liver Congress
Switching to TAF for hepatitis B improves kidney function and bone loss
Tenofovir alafenamide approved for hepatitis B in Europe
Tenofovir alafenamide approved for hepatitis B, works well with less effect on bones
